{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "randrine for 1 h , then infected with about 10 MOI of\n\nbis - benzylisoquinoline alkaloids including two benzyliso\n\nDENV - 2 .\n\nquinoline moieties linked through diphenyl ether , benzyl\n\n[ 0040 ] FIG . 8A is a plot showing the relative infectivity of\n\nphenyl ether or biphenyl bonds . Berbamine and its analogue\n\nJEV in A549 cells pretreated with 13 additionally identified\n\ncompounds .\n\nmay be artificially synthesized or may be a naturally occur\n\nring compound derived from a plant material , a fungus or the\n\n[ 0041 ] FIG . 8B shows the high - content images of A549\n\nlike .\n\ncells after immunostaining , in which the cells were pre\n\n[ 0053 ] Berbamine has a structure of Formula ( 1 )\n\ntreated with Compound # 1 , Compound # 7 , Compound # 9 or\n\nCompound # 11 respectively , then infected with about 50\n\nFormula ( I )\n\nMOI of JEV .\n\n[ 0042 ] FIG . 9A shows the cytotoxicity of berbamine in\n\nA549 cells , BHK - 21 cells , Vero cells , Hela cells , and Huh 7\n\ncells .\n\n[ 0043 ] FIG.9B illustrates the animal experiment , in which\n\nmice were injected with JEV , and then administered with\n\nPBS as the control group or berbamine as the treatment\n\ngroup .\n\n[ 0044 ] FIG.9C shows the survival rate of mice after JEV\n\nchallenge followed by treatment of berbamine for 15 days .\n\n[ 0045 ] FIG . 9D shows the body weight change of mice\n\nafter JEV challenge followed by treatment of berbamine for\n\n15 days .\n\n[ 0046 ] FIG . 10 shows the high - content images of RD cells\n\nafter immunostaining , in which the cells were pretreated\n\nwith berbamine with the indicated doses , and then infected\n\nOH\n\nwith 10 MOI of EV - 71 , as well as a plot of relative\n\n[ 0054 ] Analogues of berbamine generally share a core\n\ninfectivity of EV - 71 in the pretreated cells with EC50 being\n\nstructure of Formula ( lb ) :\n\nabout 17.3 uM .\n\n[ 0047 ] FIG . 11 shows the high - content images of A549\n\ncells after immunostaining , in which the cells were pre\n\nFormula ( Ib )", "type": "Document"}}